Industry

November 3rd online event, hosted by Wolters Kluwer, features industry experts from Brigham and Women’s Hospital in Boston, CVS Caremark, and the University of Kentucky School of Pharmacy –(BUSINESS WIRE)–Wolters Kluwer (AEX:WKL): What: Pharmacy Next: Safer, Affordable & Personalized, a Wolters Kluwer-hosted online panel of medical, retail pharmacy, and pharmacogenomics experts predicting the future of … [Read more…]

Next-generation of analytical reporting delivers fast return-on-investment by improving SPD throughput to increase surgical capacity FRANKLIN, Tenn.–(BUSINESS WIRE)–Sterile processing departments (SPDs) are under increased pressure to deliver more sterile trays to operating rooms in less time, but managers often lack the insight into where improvements can be made. The new CensisAI2 Productivity platform is the … [Read more…]

LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2022. Financial Summary and Highlights1 Revenue of $252.6 million for the quarter decreased 0.2 percent on a reported basis and increased 5.2 percent on a constant-currency basis, as compared to the prior-year period U.S. … [Read more…]

Assisting Lifestyle Changes as a Treatment for Hypertension TOKYO–(BUSINESS WIRE)–#App–CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (hereafter, CureApp HT), a DTx*1 solution treating hypertension, in Japan from September 1, 2022. Looking ahead, the app will be prescribed and provided … [Read more…]

Arcturus to receive upfront payment of $200 million and more than $4 billion in potential development and commercial milestones 40% profit sharing for COVID-19 vaccines, up to double digit royalties for influenza, pandemic preparedness and three additional respiratory infectious disease vaccines Combines Arcturus’ self-amplifying mRNA vaccine technologies with CSL’s world-leading capabilities as a commercial scale … [Read more…]

Waist to Height Ratio, known to be correlated with insulin resistance & metabolic syndrome, was a predictor of weight loss response in the study based on a post-hoc analysis As previously reported, the LIGHT-UP study met its primary endpoint with 6 out of 10 responding to the treatment, achieving an average of 11% weight loss … [Read more…]

– New findings reinforce potential of company’s multi-omics capabilities and tools in immuno-oncology to address biopharma partners’ unique oncology drug development needs – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT) announced today that three abstracts highlighting the company’s unique, multi-omics immuno-oncology capabilities and offerings will be presented at the Society for Immunotherapy of Cancer’s … [Read more…]

Increases Adjusted EBITDA Guidance to Exceed $175 million Net sales for the third quarter of $466 million, up 25 percent from prior year quarter Income from continuing operations for the third quarter of $18 million Adjusted EBITDA from continuing operations of $68 million, up 106 percent from prior year quarter Higher prices across all segments … [Read more…]

ST. PAUL, Minn.–(BUSINESS WIRE)–Christophe Beck, Ecolab Inc. chairman of the board and chief executive officer will address financial analysts at the Baird Global Industrial Conference on Tuesday, November 8. Ecolab will offer a webcast of Mr. Beck’s presentation. Details for the webcast are as follows: TIME:   12:25 pm Eastern Time       DATE: … [Read more…]

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced it will host a conference call on Tuesday, November 8, 2022, to discuss its third quarter 2022 financial results. The call will begin at 4:30 PM Eastern Time. It will be hosted by Masoud Toloue, the Company’s President … [Read more…]